Penvose, K., Havrilesky, L., Bashi, A., Rossi, E., Wright, J., Blank, S., … Myers, E. (2026). Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer. In Gynecologic Oncology (Vol. 208, pp. S48–S49). Elsevier BV. https://doi.org/10.1016/j.ygyno.2026.01.075

Penvose, Katherine, Laura Havrilesky, Aya Bashi, Emma Rossi, Jason Wright, Stephanie Blank, Benjamin Albright, Bill Hazelton, Angeles Alvarez Secord, and Evan Myers. “Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer.” In Gynecologic Oncology, 208:S48–49. Elsevier BV, 2026. https://doi.org/10.1016/j.ygyno.2026.01.075.

Penvose K, Havrilesky L, Bashi A, Rossi E, Wright J, Blank S, et al. Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer. In: Gynecologic Oncology. Elsevier BV; 2026. p. S48–9.

Penvose, Katherine, et al. “Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer.” Gynecologic Oncology, vol. 208, Elsevier BV, 2026, pp. S48–49. Crossref, doi:10.1016/j.ygyno.2026.01.075.

Penvose K, Havrilesky L, Bashi A, Rossi E, Wright J, Blank S, Albright B, Hazelton B, Secord AA, Myers E. Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer. Gynecologic Oncology. Elsevier BV; 2026. p. S48–S49.